238 related articles for article (PubMed ID: 19565512)
1. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study.
Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Karim Z; Quinn M; Wakefield R; Hensor E; Conaghan PG; Emery P
Arthritis Rheum; 2009 Jul; 60(7):1915-22. PubMed ID: 19565512
[TBL] [Abstract][Full Text] [Related]
2. Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28.
Ventura-Ríos L; Sánchez Bringas G; Hernández-Díaz C; Cruz-Arenas E; Burgos-Vargas R
Reumatol Clin (Engl Ed); 2019; 15(5):e5-e9. PubMed ID: 29198500
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints.
Picchianti Diamanti A; Navarini L; Messina F; Markovic M; Arcarese L; Basta F; Meneguzzi G; Margiotta DPE; Laganà B; Afeltra A; D'Amelio R; Iagnocco A
Clin Exp Rheumatol; 2018; 36(6):984-989. PubMed ID: 29998842
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
Janta I; Valor L; De la Torre I; Martínez-Estupiñán L; Nieto JC; Ovalles-Bonilla JG; Martínez-Barrio J; Bello N; Hinojosa M; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L; Naredo E
Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373
[TBL] [Abstract][Full Text] [Related]
5. Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
Saleem B; Keen H; Goeb V; Parmar R; Nizam S; Hensor EM; Churchman SM; Quinn M; Wakefield R; Conaghan PG; Ponchel F; Emery P
Ann Rheum Dis; 2010 Sep; 69(9):1636-42. PubMed ID: 20421345
[TBL] [Abstract][Full Text] [Related]
6. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs.
Cruces M; Al Snih S; Serra-Bonett N; Rivas JC
Reumatol Clin (Engl Ed); 2019; 15(4):218-222. PubMed ID: 29032909
[TBL] [Abstract][Full Text] [Related]
7. Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.
Ikeda K; Nakagomi D; Sanayama Y; Yamagata M; Okubo A; Iwamoto T; Kawashima H; Takahashi K; Nakajima H
J Rheumatol; 2013 Dec; 40(12):1967-76. PubMed ID: 24187096
[TBL] [Abstract][Full Text] [Related]
8. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.
Døhn UM; Ejbjerg B; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Ostergaard M
Ann Rheum Dis; 2011 Feb; 70(2):252-8. PubMed ID: 20980282
[TBL] [Abstract][Full Text] [Related]
9. Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.
Terslev L; Brahe CH; Østergaard M; Fana V; Ammitzbøll-Danielsen M; Møller T; Krabbe S; Hetland ML; Døhn UM
Arthritis Res Ther; 2021 Feb; 23(1):48. PubMed ID: 33522948
[TBL] [Abstract][Full Text] [Related]
10. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
[TBL] [Abstract][Full Text] [Related]
11. Improvement of large-joint ultrasonographic synovitis is delayed in patients with newly diagnosed rheumatoid arthritis: results of a 12-month clinical and ultrasonographic follow-up study of a local cohort.
Harman H; Tekeoğlu İ; Takçı S; Kamanlı A; Nas K; Harman S
Clin Rheumatol; 2015 Aug; 34(8):1367-74. PubMed ID: 25833144
[TBL] [Abstract][Full Text] [Related]
12. Grade and location of power Doppler are predictive of damage progression in rheumatoid arthritis patients in clinical remission by anti-tumour necrosis factor α.
Raffeiner B; Grisan E; Botsios C; Stramare R; Rizzo G; Bernardi L; Punzi L; Ometto F; Doria A
Rheumatology (Oxford); 2017 Aug; 56(8):1320-1325. PubMed ID: 28431141
[TBL] [Abstract][Full Text] [Related]
13. Intra-articular methotrexate versus corticosteroid injections in medium-sized joints of rheumatoid arthritis patients-an intervention study.
Mortada MA; Abdelwhab SM; Elgawish MH
Clin Rheumatol; 2018 Feb; 37(2):331-337. PubMed ID: 28963634
[TBL] [Abstract][Full Text] [Related]
14. Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.
Østergaard M; Emery P; Conaghan PG; Fleischmann R; Hsia EC; Xu W; Rahman MU
Arthritis Rheum; 2011 Dec; 63(12):3712-22. PubMed ID: 22127693
[TBL] [Abstract][Full Text] [Related]
15. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
Geng Y; Han J; Deng X; Zhang Z
Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
[TBL] [Abstract][Full Text] [Related]
16. Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.
Kaeley GS; Nishio MJ; Goyal JR; MacCarter DK; Wells AF; Chen S; Kupper H; Kalabic J
Arthritis Rheumatol; 2016 Nov; 68(11):2584-2592. PubMed ID: 27214046
[TBL] [Abstract][Full Text] [Related]
17. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
[TBL] [Abstract][Full Text] [Related]
18. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
19. What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.
Simpson E; Hock E; Stevenson M; Wong R; Dracup N; Wailoo A; Conaghan P; Estrach C; Edwards C; Wakefield R
Health Technol Assess; 2018 Apr; 22(20):1-258. PubMed ID: 29712616
[TBL] [Abstract][Full Text] [Related]
20. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G
Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
